ImmunityBio Inc Sustainability Reports
ImmunityBio, Inc. is a clinical-stage biotechnology company that develops next-generation immunotherapies and vaccines to bolster the natural immune system against cancers and infectious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900J9XLBR4HFL4B83
FIGI: BBG007T9DYX8
3 reports from 2021 to 2023
